OBJECTIVE: To examine the relationship of coronary estrogen receptor (ER) expression with atherosclerotic lesions and central fat accumulation in premenopausal women. SUBJECTS: A total of 52 female forensic autopsy cases aged between 18 and 49 y. METHODS: Height, body weight and waist and hip circumferences were measured and body mass index (BMI) and waist-to-hip ratio (WHR) were calculated. Intima thickness or maximal thickness of the plaque were measured from samples taken from the left anterior descending artery (LAD). Macrophage infiltration and smooth muscle cells were localized by immunostaining. ER was detected immunohistochemically and by Western blot analysis, and the ER immunopositive area in the intima was measured. RESULTS: ER immunoreactivity was observed in the intima in 60% of the samples, and it was most intense in the advanced plaques near the lipid core next to the maximal intensity of macrophage staining. The ER immunopositive area had a significant positive correlation with LAD intima thickness, which in turn was significantly correlated with waist circumference and WHR when adjusted for age and BMI. CONCLUSIONS: Premenopausal women with the central type of fat accumulation have advanced coronary plaques in which ER expression is localized near the lipid-rich and macrophage-rich zone. The higher expression of ER in the arterial plaques may represent a compensatory mechanism against atherosclerosis.
Introduction
The exact mechanisms by which estrogen provides protection against coronary heart disease (CHD) are still unclear, although some of this protection is mediated by its favorable influence on serum lipids and fibrinolytic systems and by antioxidant and vasomotor effects. 1 The direct vascular effects are mediated by a specific estrogen receptor (ER) in the arterial smooth muscle cells and endothelial cells. 1 There are rapid mechanisms, such as vasodilatation, which are produced by increased production of nitric oxide, 2 while the more long-term effects such as inhibition of smooth muscle proliferation are based on modulation of the transcriptional activity of target genes by the estrogen-ER complex. 1 Coronary atherosclerosis has been reported to be associated with certain polymorphisms of the ER gene in men, 3, 4 while women with a certain ER gene polymorphism have been observed to develop an increased level of HDL cholesterol during estrogen replacement therapy. 5 Losordo et al 6 reported an absence of ERs more often in atherosclerotic coronary arteries than in normal ones in women. ER immunoreactivity was seen in the smooth muscle cells of both the intima and media, but the authors mentioned that the pattern of the immunohistochemical staining seen in some specimens raised questions as to the precise location of the ERs. ER expression has been observed in several cell types in giant cell arteritis, including smooth muscle cells, giant cells and activated mononuclear cells, 7 and
ERs have also been observed recently in arterial mast cells. 8 An association of central obesity and coronary 9,10 as well as carotid atherosclerosis 11, 12 has been previously observed.
Women with central obesity are known to have many estrogen-related problems, such as menstrual disorders and infertility, 13 which are in turn associated with sex hormone receptors. 14, 15 Since young women with this type of fat distribution also tend to have more advanced coronary atherosclerotic lesions, 10 it is possible that the same type of dysfunction could also be found in their arterial ERs. In order to find out the expression pattern of the ER in the coronary arteries of centrally obese premenopausal women, we carried out an autopsy study of women under 50 y of age, determining the anthropometric indicators of adipose tissue distribution and localizing ER in the coronary artery samples taken at autopsy.
Methods

Subjects
Coronary arteries were collected from forensic autopsies performed at the Department of Forensic Medicine, University of Oulu, Finland, in 1997 . In all, 52 female cadavers aged between 18 and 49 y were examined and data were obtained from police records and medical records, as described previously. 10, 16 The cases consisted of 11 sudden deaths from unexpected natural causes (four cases of subarachnoid hemorrhage, two cases of pulmonary embolism, three cases of epilepsy and two cases of coronary artery disease with acute myocardial infarction), 19 accidental deaths, 20 suicides and two homicides. None of the subjects were reported to have had any hormone replacement therapy and none of them were pregnant. Their ovarial status was normal and corresponded to their age in each case. None of the subjects had been classified as alcoholics, but 14 of them were tested positive for alcohol, most of the blood concentrations being under 1.5 g/l (range 0.9-3.3 g/l). Drugs were present in 12 cases (benzodiazepines, antidepressants, carbamazepine, ibuprofen). The postmortem period was not allowed to exceed 4 days.
Anthropometric measurements
Height (cm), weight (kg), waist circumference (cm) and hip circumference (cm) were measured as described previously. 16 Body mass index (BMI; kg/m 2 ) and waist-to-hip ratio (WHR)
were calculated from these measurements.
Coronary arteries
The left and right coronary arteries were opened longitudinally and excised free from the heart, fixed in 10% neutral formalin for 24 h and samples were taken from the anterior descending artery (LAD), circumflex artery (CX) and right coronary artery (RCA), as described previously. 16 
Histology and immunohistochemistry
The paraffin-embedded coronary artery samples, sectioned at 5 mm, were stained by the Verhoeff-Masson trichrome method, 17 in which collagen is colored green, smooth muscle red and elastic fibers black. Macrophage foam cells were detected immunohistochemically with a CD68 antibody (Dako), and smooth muscle cells with a monoclonal mouse anti-human smooth muscle actin antibody (Dako). Two monoclonal antibodies against ER alpha were used, ER from Dako and ERa from Santa Cruz. Sections were incubated with the antibody (1 : 100) for 30 min and thereafter with an EnVision kit from Dako. ER-positive breast carcinoma tissue (Dako) served as the positive control, and slides without primary antibody as the negative control.
Western blot analysis
The four cases with the shortest postmortem interval, not exceeding 36 h, were taken for Western Blot analysis. Samples were frozen in liquid nitrogen and stored at À701C. The frozen samples were homogenized in Trisglycine-SDS buffer and boiled in a water bath for 3 min. The proteins were separated out electrophoretically and transferred to a nitrocellulose membrane. The MCF-7 wholecell lysate (Santa Cruz) was used as a control. After blocking the nonspecific binding sites, the membrane was incubated with the mouse monoclonal ER antibody, 1 : 5000 (ERa F-10, Santa-Cruz). It was then washed and incubated with an HRPconjugated secondary antibody, 1 : 100 000 (goat Anti-Mouse IgG-HRP conjugate, Bio-Rad). The chemiluminescent method (SuperSignal s West Pico Substrate, Pierce) was adopted for visualization, using a standard X-ray film.
Morphometric measurements on coronary artery samples Since LAD was most frequently affected by atherosclerotic lesions, and by the most advanced lesions, samples taken from this vessel were chosen for morphological measurements to be performed by computerized image analysis (Image Tool, University of Texas Health Science Center in San Antonio). Only those sections in which all the layers were completely visible without any damage produced by tissue processing were chosen. The thickness of the intimal layer was measured in the samples in which the intima was of normal appearance or showed some diffuse thickening. In the samples with intimal lesions, the maximal thickness of each lesion was measured as described previously. 16 Plaque areas were not measured, because the boundaries of the plaques could be outlined only in cases with advanced lesions having lipid cores but not in less severe lesions. The immunopositive area for ER in the intima of each sample was measured.
Statistical analysis
The statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) software. All variables except height showed skewness in their distribution, and 
Results
Descriptive statistics
Descriptive statistics for the material are presented in Table 1 . There were wide variations in the indicators of body size and the anthropometric indicators of fat distribution.
Coronary arteries
In all, 40% of the subjects did not have any lesions in their coronary arteries. Normal arteries were seen predominantly in the youngest subjects, but there were three women over 40 y of age, who did not have even fatty streaks. Fatty streaks and fibrous plaques were seen at all ages, and advanced lesions with lipid cores were already present in the age group between 20 and 30 y.
Morphometric measurements and immunohistochemistry
The intima thicknesses and ER immunoreactive areas are presented in Table 2 . The most intense intimal ER immunoreactivity was seen in the advanced plaques near the lipid core, next to the region with the most intense macrophage staining, whereas collagen-rich plaques with only small amounts of macrophages did not show much ER positivity. ER-positive areas did not show much positive staining for smooth muscle actin. Breast carcinoma tissue was strongly ER positive (Figure 1a-d) . Only a few occasional ER-positive smooth muscle cells were seen in the media of the coronary samples, and no intense staining was seen in any of these samples.
The intima thickness of LAD showed a significant positive correlation with age (r ¼ 0.390, P ¼ 0.005), as also did waist circumference (r ¼ 0.343, P ¼ 0.014), but not the other indicators of obesity. The intima thickness of LAD had a significant positive correlation with waist circumference (r ¼ 0.344, P ¼ 0.018) and with WHR (r ¼ 0.387, P ¼ 0.007), when adjusted for age and BMI. The bivariate correlation between LAD intima thickness and ER immunoreactive area was significant (r ¼ 0.587, P ¼ 0.000) and the age-adjusted correlation was also significant (r ¼ 0.506, P ¼ 0.000) ( Table 2 ). The correlations between ER immunoreactive area and waist circumference or WHR were not significant when adjusted for age and BMI.
Western blot analysis
An example of a Western blot analysis is presented in Figure 2 . There was a close correspondence between the bands in the breast tumor control and the arterial samples. The upper band of the samples taken from LAD corresponded to the major band in the tumor control, having a molecular weight of approximately 64 kDa. In addition, another band corresponding to 54 kDa was present in both arterial and tumor samples.
Discussion
The premenopausal women with the central type of fat accumulation had advanced coronary lesions in which ER expression was localized near the lipid core, next to the macrophage-rich zone, whereas the arterial media showed only weak immunoreactivity. The present results differed somewhat from earlier observations, since we did not find any specific data in the few earlier studies on ER expression in various types of arteriosclerotic plaques. This could be at least partly due to differences in the material and laboratory methods. As mentioned by Losordo et al, 6 there can be difficulties in detecting ERs in specimens stored in formalin. The storage time for our material did not exceed 36 h. ER expression in the collagen-rich plaques in our material was not as intense as that in the lipid-and macrophage-rich plaques with thin collagen caps, suggesting that the composition of the plaque may be more important for ER expression and estrogen function than the degree of narrowing caused by the plaque. Coronary estrogen receptors in premenopausal women M-L Kortelainen and P Huttunen ER-positive areas in the plaques did not contain many smooth muscle actin-positive cells. It is possible that activated ER may be localized mainly in smooth muscle cells with a different phenotype, and this could be associated with a remodelling process in the plaque. Matrix metalloproteinase (MMP) enzymes are produced by macrophages and they participate in the remodelling process by degrading extracellular matrix components, 18 and activation of ER by estrogen is related to the accelerated tissue expression of MMPs. 19 Proteolytic enzymes are beneficial for preventing any further narrowing of an artery, but in the case of advanced plaques with large lipid cores and thin collagen caps it may in turn increase the instability of the plaque. 18 This could be related to the recently presented results suggesting that hormone replacement therapy could even be harmful to some women. 20 Inflammation probably activates the ER, as seems to happen in giant cell arteritis. 7 The ER immunoreactivity observed in the present material could be associated with chronic inflammation in the atherosclerotic plaque. Inflammation is not as evident in less severe lesions as it is in advanced, macrophage-rich plaques, but it could be marked enough to cause activation of the receptor. The ER immunoreactivity observed here could also be associated with the well-known antioxidant effect of estrogen, 21 an effect that may be due to ER-mediated changes in the expression of genes for enzymes that regulate the local production and degradation of superoxide. 22 The localization of ER in the coronary plaques was very similar to that observed earlier with oxidized low-density lipoprotein. 23 It is also possible that women with abdominal obesity may have functional disturbances in their ERs, or that their arterial tissues express variant forms of ER which may have anomalous transcriptional activities and may inhibit or enhance the effect of wild-type receptors. 24 Hodges et al 24 have recently reported exon deletion variants of ERs in human vascular smooth muscle.
In conclusion, ER immunoreactivity is seen close to the lipid core and next to the macrophage-rich area in the coronary plaques of young and premenopausal women with a tendency for abdominal fat accumulation. It may well be that the higher expression of ER in arterial plaques may represent a compensatory mechanism against arteriosclero- 
Coronary estrogen receptors in premenopausal women
M-L Kortelainen and P Huttunen sis. It remains to be studied in the future whether variant forms of ER and polymorphisms of the ER coding gene have a role in the atherosclerotic process of centrally obese premenopausal women.
